Fund raising
Jodie Simpson and Lynn Richards, residents of Walnut Grove's Chartwell Green 55-plus community, have been tirelessly collecting returnable bottles and cans to raise funds for the Alzheimer Society of B.C. The amateur fundraisers, who refer to themselves as the "lollygaggers," have collected over $55,000,
Alzheimer's disease
As September is World Alzheimer's Month, many caregivers are reminded of the importance of maintaining their own mental, emotional, and physical well-being while supporting a loved one with Alzheimer's. Behind the quiet strength of caregiving lies an often-overlooked reality - looking after someone else means you
Diseases
The U.S. Food and Drug Administration (FDA) has announced the approval of Leqembi Iqlik, a subcutaneous formulation of the Alzheimer's medication lecanemab, for weekly maintenance dosing following an 18-month IV initiation phase. This advancement marks a significant shift towards making the treatment more accessible for patients, paving
Diseases
New research on Coronavirus - COVID-19 has revealed concerning findings on the potential long-term effects of the virus on older adults. According to the study, individuals who experience lingering symptoms following SARS-CoV-2 infection, known as long COVID, may be at risk of accelerating cognitive decline and neurodegeneration. The research, conducted
Diseases
Advances in gene editing technologies, particularly next-generation CRISPR systems, offer promising solutions for the treatment of Alzheimer's and Parkinson's diseases. These technologies, including base editing, prime editing, and engineered Cas variants, have shown improved fidelity and potential for precise gene correction, transcriptional repression or activation, and
Diseases
The Alzheimer's disease market, particularly the agitation subset, is expected to experience a substantial increase in market size, primarily driven by the aging population, especially in developed countries where Alzheimer's disease prevalence is higher. Emerging therapies, such as TransCon hGH, HyTropin (GX-H9), Somatrogon, and others, are
Diseases
DelveInsight's analysis highlights that the Alzheimer's Disease pipeline comprises over 110 key companies actively engaged in developing more than 120 treatment therapies. The report provides comprehensive insights into the clinical development activities of the Alzheimer's Disease therapeutics market, including the therapeutic assessment by product
Alzheimer's disease
Ruth Langsford, TV presenter, has been dealing with a challenging few years, including her parents' struggles with Alzheimer's disease. Her mum, Joan, lives in a care home, and Ruth has taken on the role of her main carer. Despite the difficulties, Ruth focuses on caring for her
Diseases
New research published in the journal Proteins: Structure, Function, and Bioinformatics has shed light on the interactions between amyloid-beta peptides and neuronal membranes in the development of Alzheimer's disease. Investigating the role of ganglioside monosialotetrahexosylganglioside (GM1) lipids in the disease process, researchers from the University of Paris discovered
Manchester United Football Club
Legendary footballer Denis Law, who died in January at the age of 84, left behind an estate worth £2,035,475. The Manchester United great's assets were probated and went to his wife Diana and their family. Law's remarkable career, marked by his goalscoring courage and
Diseases
As the leading cause of dementia, Alzheimer's disease affects millions worldwide, with over 110 key companies actively developing more than 120 treatment therapies. DelveInsight's "Alzheimer's disease Pipeline Insight, 2025" report provides a comprehensive analysis of the clinical development activities and growth prospects
Diseases
Women with Down syndrome may develop Alzheimer's disease more rapidly than men, with more advanced signs of the disease at the average age of diagnosis. Brain tissue studies reveal more beta amyloid and tau accumulation in women with Down syndrome than in men, indicating a higher burden of
